In vitro Diagnostics Market Report: Global Insights, Opportunities, and Forecast 2025-2032

The global in-vitro diagnostics (IVD) market was valued at USD 73.99 billion in 2024 and is projected to grow from USD 77.73 billion in 2025 to USD 117.60 billion by 2032, exhibiting a CAGR of 6.1% during the forecast period. North America dominated the IVD market in 2024, accounting for a market share of 37.71%.

In-Vitro Diagnostics (IVD) are medical instruments that carry out a wide range of diagnostic tests on biological samples, such as urine, blood, saliva, and tissues. These tests assist medical professionals in determining chronic ailments, such as infectious diseases and autoimmune disorders. They can also be used to study drug therapy modifications at regular intervals. The increasing demand for technologically advanced diagnostic machines to carry out several innovative tests for complex diseases will positively impact the market's growth.

Fortune Business InsightsTM provides this information in its research report, titled "In vitro Diagnostics Market, 2025- 2032".

List Of Key Companies Mentioned in the In vitro Diagnostics Market:
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Abbott (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Sysmex Corporation (Japan)
• Siemens Healthineers AG (Germany)
• BD (U.S.)
• Seegene Inc. (Republic of Korea)
• DiaSorin S.p.A. (Italy)
• Quest Diagnostics Incorporated (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)

Get a Free Sample Research PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/in-vitro-diagnostics-ivd-market-101443

Market Segmentation:

Growing Use of Innovative Testing Kits Boosted Demand for Reagents & Consumables
Based on product type, the market is divided into instruments and reagents & consumables. The reagents & consumables segment held a dominant position in the market in 2024 as patients and healthcare alike are increasingly using innovative testing kits, such as POC tests and self-testing kits, to diagnose chronic health conditions.

Launch of Cutting-Edge Molecular Diagnostic Products Fueled Their Demand
Based on technique, the market is divided into immunodiagnostics, clinical chemistry, molecular diagnostics, hematology, and others. The molecular diagnostics segment dominated the market in 2024 as several leading market players are introducing cutting-edge molecular diagnostic products to diagnose several chronic diseases.

Benefits of Blood Tests in IVD Helped Blood Segment Dominate Market
Based on sample, the market is segmented into blood, urine, saliva, tissue, and others. The blood segment dominated the global in-vitro diagnostics (IVD) market share in 2024, as there are several benefits associated with blood tests. These include better diagnosis of a disease, high efficiency, and accurate monitoring of an ailment.

Rising Investments in Infrastructure Boosted Product Use in Laboratories
Based on setting, the market is bifurcated into laboratories and point-of-care. The laboratories segment dominated the market in 2024 as several public and private entities are increasing their investment in laboratory infrastructure in emerging countries to improve patient outcomes. This will increase the use of in-vitro diagnostics (IVD) devices to help clinicians offer better and more accurate diagnosis of ailments.

Rising Prevalence of Infectious Diseases Increased Demand for In-Vitro Diagnostics
Based on application, the market is divided into infectious diseases, cardiology, oncology, gastroenterology, allergy, autoimmunity, prenatal screening, and others. The infectious disease segment held the largest market share in 2024 due to the rising incidence of chronic infectious diseases.

Clinical Laboratories Increased Product Use Owing to Outsourcing of Clinical Diagnostic Services
Based on end-user, the market is segmented into clinical laboratories, hospitals, physician's offices, and others. The clinical laboratories segment dominated the market in 2024 as an increasing number of hospitals are outsourcing their clinical diagnostic services to independent laboratories to reduce their workload.

Report Coverage:
The report has conducted a detailed study of the market and highlighted several critical areas, such as leading product types, techniques, samples, settings, applications, end-users, and prominent market players. It has also focused on the latest market trends and the key industry developments. Apart from the aforementioned factors, the report has given information on many other factors that have helped the market grow.

Drivers and Restraints:
Rising Government Support for Developing Innovative IVD Instruments to Boost Market Growth
Governments across the world are offering their support to the development and introduction of innovative and technologically advanced in-vitro diagnostic (IVD) devices as they want to promote the benefits and importance of getting an early diagnosis. The use of such devices will help medical professionals diagnose a vast array of life-threatening diseases in their early stages, thereby improving patients' survival rates.
However, the high cost of purchasing and maintaining these devices can hinder the in-vitro diagnostics (IVD) market growth.

Explore the full research report with detailed insights and TOC:
https://www.fortunebusinessinsights.com/industry-reports/in-vitro-diagnostics-ivd-market-101443

Regional Insights:
North America Dominated Market Due to Vast Presence of Key Players
North America dominated the market in 2024 and the region might maintain its dominance during the forecast period as well due to the presence of prominent market players, such as Thermo Fisher Scientific, Abbott, and Danaher Corporation. Moreover, favorable government regulations promoting the use of in-vitro diagnostic devices will further accelerate the regional market's growth.
Europe is expected to be the second-dominating region in the global market as the region has a robust healthcare infrastructure, and governments are increasing their spending on the healthcare sector.

Key Industry Development:
December 2023 - Sysmex Corporation announced the launch of its reagents. These reagents will be utilized in blood testing to detect the accumulation of Amyloid Beta (Aβ) in the brain. This launch was expected to help the firm expand its current product portfolio in Europe.

Contact Us:
Fortune Business InsightsTM Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
US +1 833 909 2966 (Toll Free)
UK +44 808 502 0280 (Toll Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Fortune Business InsightsTM offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.